A new study has dismissed the role of the estrogen drug Raloxifene in the improvement of the memory and thinking skills of women who were suffering from dementia brought about by Alzheimer's disease. This is contrary to a previous study suggesting that the drug may lower the risk of cognitive impairment or dementia.
